Benzo[a]pyrene-induced DNA-protein crosslinks in cultured human lymphocytes and the role of the GSTM1 and GSTT1 genotypes.

We investigated the influence of glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) polymorphisms upon DNA-protein crosslinks (DPC) induced by benzo[a]pyrene (B[a]P) in cultured human lymphocytes. Lymphocyte samples were collected from 30 healthy nonsmoking hospital administrative workers. DPC was detected with KCl-SDS assay and the distributions of GSTM1 and GSTT1 were determined by polymerase chain reaction. B[a]P was found to induce a significant dose-responsive increase in cytotoxicity and DPC regardless of the genotypes (p<0.05). We did not find statistically significant genetic modification effect of GSTM1 and GSTT1 polymorphisms in the cytotoxicity and DPC formation (p>0.05). In terms of the genes examined, the level of cytotoxicity and DPC formation were found to be highest in the GSTM1-null and GSTT1-null cells. In conclusion, B[a]P induced a significant increase in the cytotoxicity and the level of DPC formation in cultured human lymphocytes. Our findings suggest that DPC could be used as a biomarker of B[a]P exposure.

[1]  F. V. van Schooten,et al.  Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes. , 2000, Carcinogenesis.

[2]  E. Ha,et al.  Influence of genetic susceptibility on the urinary excretion of 8-hydroxydeoxyguanosine of firefighters , 2000, Occupational and environmental medicine.

[3]  S. Z. Abdel‐Rahman,et al.  Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. , 1999, Pharmacogenetics.

[4]  A. Zhitkovich,et al.  Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. , 1999, Mutation research.

[5]  H. Norppa,et al.  Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1,2-epoxy-3-butene. , 1999, Mutation research.

[6]  M. Spitz,et al.  Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States) , 1997, Cancer Causes & Control.

[7]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[8]  H. Norppa.  Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. , 1997, Environmental health perspectives.

[9]  C. Matthias,et al.  Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. , 1996, American journal of surgery.

[10]  C. Bloomfield,et al.  Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect , 1996, The Lancet.

[11]  K. Richert-Boe,et al.  Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  J. Freudenheim,et al.  Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.

[13]  K. Pelin,et al.  Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. , 1995, Cancer research.

[14]  M. Spitz,et al.  Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. , 1995, Carcinogenesis.

[15]  T. Katoh,et al.  Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. , 1995, Carcinogenesis.

[16]  F. Perera,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. , 1994, Carcinogenesis.

[17]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[18]  N K Spurr,et al.  Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. , 1993, Carcinogenesis.

[19]  H Vainio,et al.  The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. , 1993, Carcinogenesis.

[20]  A. Zhitkovich,et al.  DNA-protein cross-links in welders: molecular implications. , 1993, Cancer research.

[21]  G. Talaska,et al.  The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. , 1992, Environmental health perspectives.

[22]  A. Zhitkovich,et al.  A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. , 1992, Carcinogenesis.

[23]  F. Kok,et al.  Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. , 1992, Carcinogenesis.

[24]  P. Vineis,et al.  Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. , 1991, Pharmacogenetics.

[25]  C. Angeletti,et al.  Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. , 1991, Carcinogenesis.

[26]  D. Nebert.  Role of genetics and drug metabolism in human cancer risk. , 1991, Mutation research.

[27]  H. Heck,et al.  Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer 344 rats: analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[28]  R. Jamasbi,et al.  Growth inhibition and DNA damage induced by benzo[a]pyrene and formaldehyde in primary cultures of rat tracheal epithelial cells. , 1988, Mutation research.

[29]  X. W. Wang,et al.  Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. , 1986, Cancer research.

[30]  S. Z. Abdel‐Rahman,et al.  GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. , 1998, Cancer detection and prevention.

[31]  Wun-Jae Kim,et al.  A case-control study on the effects of the genetic polymorphisms of N-acetyltransferase 2 and glutathione S-transferase mu and theta on the risk of bladder cancer , 1998 .

[32]  J. Ribak,et al.  DNA--protein crosslinks, a biomarker of exposure to formaldehyde--in vitro and in vivo studies. , 1996, Carcinogenesis.

[33]  C. Wolf.  Metabolic factors in cancer susceptibility. , 1990, Cancer surveys.

[34]  Wolf Cr.  Metabolic factors in cancer susceptibility. , 1990 .

[35]  B. Mannervik,et al.  Glutathione transferases--structure and catalytic activity. , 1988, CRC critical reviews in biochemistry.

[36]  S. Patierno,et al.  DNA-protein cross-links induced by nickel compounds in intact cultured mammalian cells. , 1985, Chemico-biological interactions.